Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Anxiety Disorders

Trial Information

The study is looking at the metabolic side effects of the new antipsychotic medications. Participants should be stable on one of the following medications: olanzapine (zyprexa), ziprasidone (geodon), risperidone (risperdal) or aripiprazole (abilify). Patient's medications won't be changed. The study involves 3 visits at the Palo Alto VA and Stanford Hospital.

Gaining Weight On Your Medication? Find Out Your Risk for Diabetes!

We are looking for Men and Women 25 to 66 years old, and... Overweight

Already taking one of these medications

• Olanzapine (Zyprexa®)
• Ziprasidone (Geodon®)
• Aripiprazole (Abilify®)
• Risperidone (Risperdal®)

Stanford University Medical Center and the Palo Alto VA under Dr. Gerald Reaven and Dr. Steven Lindley are seeking volunteers for a study on certain mediations and effects on risk for type 2 diabetes. Non-diabetic volunteers on one of the medications described above will receive a free medical examination, a cholesterol panel, and test to determine personal risk for diabetes and heart disease. This study offers $320 compensation for your time.

Call Lilla Nikolics for more information: 650-493-5000 x 67289

Patient Inclusion Criteria:

• 25 to 66 years old
• body mass index (BMI) >25 < 35 kg/m2
• on a stable dose of olanzapine, risperidone, ziprasidone or aripiprazole for at least 3 months.

Patient Exclusion Criteria:

• No medications that directly affect insulin-mediated glucose disposal
• No intense suicidal impulses/intent
• No alcohol or substance abuse for 3 months.
• No major medical problems, i.e., clinically unstable medical disorder or condition; cardiovascular, hepatic, renal, gastrointestinal, pulmonary, endocrine or other systemic disease that would, in the investigator's clinical judgment interfer with the endocrine measures obtained in this study.

Lilla Nikolics, Research Assistant
Stanford University School of Medicine
Stanford/VA Aging Clinical Research Center 3801 Miranda Avenue, 151Y
Palo Alto, CA 94304
Phone: 650-493-5000 x67289
EMail: olanzapine.research@gmail.com

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.